-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CNT-101 in Oral Mucositis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CNT-101 in Oral Mucositis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CNT-101 in Oral Mucositis Drug Details: KMRC-011 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CNT-101 in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CNT-101 in Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CNT-101 in Radiation Toxicity (Radiation Sickness, Acute...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bintrafusp Alfa in Oropharyngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bintrafusp Alfa in Oropharyngeal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bintrafusp Alfa in Oropharyngeal Cancer Drug Details: Bintrafusp alfa is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Naltrexone in Psychiatric Disorders
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Naltrexone in Psychiatric Disorders Drug Details: Naltrexone is under development for the treatment of postherpetic...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Ciforadenant in Relapsed Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ciforadenant in Relapsed Multiple Myeloma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ciforadenant in Relapsed Multiple Myeloma Drug Details: Ciforadenant is under development...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – BDB-201 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BDB-201 in Solid Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BDB-201 in Solid Tumor Drug Details: Orien X-010 (BDB-201) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – DA-2811 in Type 2 Diabetes
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DA-2811 in Type 2 Diabetes report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. DA-2811 in Type 2 Diabetes Drug Details: DA-2811 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EG-001 in Idiopathic Interstitial Pneumonia (IIP)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EG-001 in Idiopathic Interstitial Pneumonia (IIP) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.EG-001 in Idiopathic Interstitial Pneumonia (IIP)Drug Details:EG-001 is under development for...